Andréa Buchmuller

Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial

Ingrid M. Bistervels, Andréa Buchmuller, Hanke M.G. Wiegers et al. · The Lancet · 2022 · 93 citations · Full text

Treatment of proximal deep vein thrombosis with a novel synthetic compound (SR90107A/ORG31540) with pure anti-factor Xa activity - A phase II evaluation

HR Büller, R Cariou, Alexander Gallus et al. · University of Groningen research database (University of Groningen / Centre for Information Technology) · 2000 · 82 citations

Novel Synthetic Compound, Mg Sr90107a/org31540, Pharmacotherapy +22

Diagnosis of Pulmonary Embolism in Patients with Proximal Deep Vein Thrombosis

Philippe Girard, M. Décousus, Silvy Laporte et al. · American Journal of Respiratory and Critical Care Medicine · 2001 · 68 citations

Thrombosis, Pulmonary Embolism, Venous Thrombosis +14

Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses

Suzanne M. Bleker, Andréa Buchmuller, Céline Chauleur et al. · Thrombosis Research · 2016 · 52 citations · Full text

Thrombosis, Venous Thrombosis, Postpartum Hemorrhage +12

Clinical relevance of symptomatic superficial-vein thrombosis extension: lessons from the CALISTO study

Alain Leizorovicz, F. Becker, Andréa Buchmuller et al. · Blood · 2013 · 45 citations